Hosted on MSN20d
FDA recognizes need for immunogenicity assays in therapeutics with carriers or conjugatesMore information: David P. Chimento et al, Bioanalytical Assays for Oligonucleotide Therapeutics: Adding Antibody-Based Immunoassays to the Toolbox as an Orthogonal Approach to LC-MS/MS and Ligand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback